About Us
Company Profile
Corporate Culture
Development
Organizational
Responsibility
Partners
Business Scope
CRO Services
Transformation Of Hospital Preparations
Registration Affairs
Medical Services
Cultivation Of Major TCM Varieties
SMO Service
Therapeutic Area
Breathe
Gynecology And Reproductive Medicine
Pediatrics
Tumor
Orthopedics
Cardiovascular And Cerebrovascular
Digestion
Endocrinology And Metabolism
Dermatology
Proctology
Urology
Neurological And Psychiatric Disorders
Qualification And Honor
Qualification And Honor
News
Company News
Industry News
Contact Us
EN
中文 EN
Company News
Industry News
Home - News and Information
News and Information
Evidence-Based Empowerment | Lead Site Initiation Meeting for the Bailing Tablets Clinical Trial in the Treatment of Vitiligo Successfully Held
On August 3, the lead site initiation meeting for the clinical trial on the efficacy and safety of Bailing Tablets in the treatment of non-segmental slowly progressive vitiligo was successfully held in the academic hall on the first floor of the Department of Dermatology at the First Affiliated Hospital of Air Force Medical University.
2026-08-03
Insight into Hong Kong & Macao, Building Bridges for Global Expansion" — Evidence-Based Research on the Hong Kong and Macao Registration Pathways for Pharmaceutical Enterprises in the Greater Bay Area
In-Depth Analysis of Compliance Pathways for Greater Bay Area TCM Enterprises "Going Global": A Comprehensive Guide to Hong Kong's HKC Tiered Review Policy, Macao's Fast-Track "Non-Drug" Filing, and Greater Bay Area Two-Way Simplified Registration, with Real-World Case Studies and Key Pitfalls to Avoid
2026-07-25
Good News | Guangzhou EBM Elected as Council Member Unit of the Second Council of the Evidence-Based Medicine Branch, China Ethnic Medicine Association
From June 26 to 29, 2026, the 2026 Annual Academic Conference of the Evidence-Based Medicine Branch of the China Ethnic Medicine Association was grandly held in Hohhot, Inner Mongolia Autonomous Region.
2026-06-30
When a Millennium-Old Classic Formula Meets the "Research-Oriented Pharmacy" – Xiao Chai Hu Granules Real-World Study Project Launched at Beijing Tongrentang Foshan Chain
On the afternoon of June 24, the "Guanghua Xiao Chai Hu Granules – Beijing Tongrentang Foshan Chain Research-Oriented Pharmacy Real-World Study Project" deployment meeting was held at the headquarters of Beijing Tongrentang Foshan Chain Pharmacy. This marks another significant deployment of the project in Guangdong following its launch in Guangzhou, signaling that the nation's first OTC drug research-oriented pharmacy project has officially entered the Foshan market.
2026-06-24
2025 Drug Clinical Trial Volume Reaches New High, Offering New Treatment Options for Patients
The National Medical Products Administration (NMPA) released the 2025 Annual Report on the Progress of New Drug Registration Clinical Trials in China, reporting 5,215 clinical trial registrations for the year, surpassing 5,000 for the first time. Category I innovative drugs accounted for 72.4% of all new drug trials, with Phase I innovative drug trials ranking first globally. The report provides a comprehensive review of clinical trial data across multiple therapeutic areas, including anti-tumor drugs, weight-loss medications, cell and gene therapies, pediatric medicines, and rare disease drugs, while also offering insights into the current state of China’s original innovation capabilities in new drug R&D and the development of international multi-regional clinical trials.
2026-06-24
From Evidence to Intelligent Evidence: Salon on AI New Paradigm for TCM Enterprises Concludes Successfully
On May 28, Guangzhou Evidence-Based Medicine Technology Co., Ltd. (hereinafter referred to as "Guangzhou EBM"), together with the Greater Bay Area Chapter of the CEIBS Healthcare Industry Association, visited the Alibaba Center in Guangzhou to co-host the "In-Depth Closed-Door Meeting on AI Transformation Implementation for Pharmaceutical Enterprises" in partnership with DingTalk Wukong and Maolu Academy. The event was designed to help healthcare companies break through barriers in compliance, data management, and cross-functional collaboration, enabling a systematic leap from individual productivity enhancement to organizational evolution.
2026-05-28
Embracing the AI Era, Empowering Organizational Evolution – Guangzhou EBM Management Team Attends AI Hands-On Training at Alibaba Center Guangzhou
Embracing the AI Era, Empowering Organizational Evolution – Guangzhou EBM Management Team Attends AI Hands-On Training at Alibaba Center Guangzhou
2026-05-18
2026-08-14
External Expert Reappointment List of the Center for Drug Evaluation (2026 First Batch) (Draft for Comments)
In order to ensure the scientific and impartial nature of drug evaluation and fully leverage the role of external experts in the drug review process, and in accordance with the Measures for the Management of External Experts of the Center for Drug Evaluation, the Center for Drug Evaluation has organized and carried out the reappointment of external experts. External experts submitted reappointment applications to the Center based on factors such as personal willingness, age, and conflicts of interest. After review by the Center in accordance with established procedures, the External Expert Reappointment List of the Center for Drug Evaluation (2026 First Batch) (Draft for Comments) has been formulated.
2026-08-10
Four Departments Jointly Issue: The New Edition of the Good Clinical Practice for Drug Trials Is Here!
Today (June 8), in order to optimize the quality management of drug clinical trials, further cultivate a standardized and efficient clinical R&D ecosystem, and support biopharmaceutical R&D innovation, the National Medical Products Administration, together with the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control Administration, issued the revised Good Clinical Practice for Drug Trials (Announcement No. 50 of 2026).
2026-08-03
Evidence-Based Empowerment | Lead Site Initiation Meeting for the Bailing Tablets Clinical Trial in the Treatment of Vitiligo Successfully Held
On August 3, the lead site initiation meeting for the clinical trial on the efficacy and safety of Bailing Tablets in the treatment of non-segmental slowly progressive vitiligo was successfully held in the academic hall on the first floor of the Department of Dermatology at the First Affiliated Hospital of Air Force Medical University.
2026-07-25
Insight into Hong Kong & Macao, Building Bridges for Global Expansion" — Evidence-Based Research on the Hong Kong and Macao Registration Pathways for Pharmaceutical Enterprises in the Greater Bay Area
In-Depth Analysis of Compliance Pathways for Greater Bay Area TCM Enterprises "Going Global": A Comprehensive Guide to Hong Kong's HKC Tiered Review Policy, Macao's Fast-Track "Non-Drug" Filing, and Greater Bay Area Two-Way Simplified Registration, with Real-World Case Studies and Key Pitfalls to Avoid
2026-07-09
Notice on the Issuance of the National Essential Medicines List (2026 Edition)
In order to implement the decisions and arrangements of the Party Central Committee and the State Council, and to consolidate and improve the national essential medicines system, and in accordance with the Basic Healthcare and Health Promotion Law, the Drug Administration Law, and other legal provisions, the National Health Commission has organized the updating and revision of the National Essential Medicines List (2018 Edition), and has formulated the National Essential Medicines List (2026 Edition).
2026-06-30
Good News | Guangzhou EBM Elected as Council Member Unit of the Second Council of the Evidence-Based Medicine Branch, China Ethnic Medicine Association
From June 26 to 29, 2026, the 2026 Annual Academic Conference of the Evidence-Based Medicine Branch of the China Ethnic Medicine Association was grandly held in Hohhot, Inner Mongolia Autonomous Region.
1
2
3
Online Message

With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.

The business area you want to consult